...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: NIH's Long-COVID studies
7
Jul 08, 2022 12:55PM
1
Jul 09, 2022 07:36AM

KK2. the NIH provides funding for trials.  That was the thrust of the message.  Money is what we are missing.  We can be granted all the FDA designations and special meetings in the world but if we have a CEO who can't raise $50 million for a piece of a slam-dunk blockbuster drug (and maybe that times ten over) then nothing else matters.
jmho

1
Jul 09, 2022 04:12PM
Share
New Message
Please login to post a reply